Trial Profile
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs MTC 896 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Mimetica
- 14 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Apr 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 25 Mar 2015 New trial record